Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MRNA · against 44 other Healthcare companies of similar size
Ranked #45 of 45 · scores higher than 0% of peers
Bars: peers in each 10-point band of the profitability score1 peers with a profitability score of 10–19, including MRNA · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | MRNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 43 reported | -46.6% | 11.5% | 0% | 33% | |
| Operating marginHigher is better · 44 reported | -149.0% | 21.6% | 0% | 33% | |
| Return on assetsHigher is better · 44 reported | -28.7% | 7.5% | 0% | 33% | |
| Return on equityHigher is better · 40 reported | -39.0% | 13.5% | 0% | Context only | |
| Gross marginHigher is better · 45 reported | -66.0% | 59.1% | 0% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 11.26T JPY (≈$76.6B) | 99 | 72 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 177.5B USD | 99 | 71 | |
| 4 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 5 | 534.1B HKD (≈$68.4B) | 96 | 75 | |
| 41 | 50.2B USD | 50 | 49 | |
| 42 | 116.9B USD | 44 | 47 | |
| 43 | 66.3B USD | 37 | 30 | |
| 44 | 56.0B USD | 26 | 39 | |
| 45 | 91.2B USD | 14 | 18 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score